Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06918119 · ClinicalTrials.gov registry record · NA
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
A NA study of Spina Bifida and Myelomeningocele, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06918119: Recruiting NA study of Spina Bifida and Myelomeningocele, sponsored by Mayo Clinic.
NCT06918119 is a NA study of Spina Bifida and Myelomeningocele that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 51-participant average among 16 other Spina Bifida trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06918119, a NA study of Spina Bifida and Myelomeningocele, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A study to use transcutaneous spinal cord stimulation to characterize sensorimotor deficits in a pediatric population of individuals with spina bifida.
Primary Outcome
Measuring muscle strength and function using the Daniels and Worthingham's Muscle Grading Scale. A physical therapist will use a 5-point scale to manually test the 5 lower extremity muscles on each side, with 0 being no visible or palpable contraction, up to 5 being full range of motion against gravity with maximal resistance. The maximum total score would be 50.
Conditions Studied
Interventions
- DEVICE Transcutaneous stimulation
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-07 |
| Est. Completion | 2030-07 |
| Phase | NA |
What NCT06918119 shows while recruiting
NCT06918119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 51-participant average among 16 other Spina Bifida trials with a reported enrollment target (41% lower).
The record links to 2 conditions, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous stimulation is the first listed.
NCT06918119 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06918119 about?
NCT06918119 is a clinical study titled "Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida". A study to use transcutaneous spinal cord stimulation to characterize sensorimotor deficits in a pediatric population of individuals with spina bifida.
What is the current status of trial NCT06918119?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-07. Estimated completion is 2030-07.
What conditions does trial NCT06918119 study?
This clinical trial studies the following conditions: Spina Bifida, Myelomeningocele.
What interventions are being tested in trial NCT06918119?
The interventions under investigation include: Transcutaneous stimulation (DEVICE).
Who is sponsoring clinical trial NCT06918119?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06918119 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06918119's enrollment target sits among peer trials
30 8th of 16 higher than 8 of 16 other Spina Bifida trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spina Bifida trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
In-Utero Endoscopic Correction of Spina Bifida
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI